1. Aleglitazar, a dual peroxisome proliferator‐activated receptor‐α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double‐blind trial. Issue 7 (1st February 2016) Authors: Stirban, A. O.; Andjelkovic, M.; Heise, T.; Nosek, L.; Fischer, A.; Gastaldelli, A.; Herz, M. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 7(2016) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials. Issue 6 (8th April 2015) Authors: Henry, R. R.; Buse, J. B.; Wu, H.; Durrwell, L.; Mingrino, R.; Jaekel, K.; El Azzouzi, B.; Andjelkovic, M.; Herz, M. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials. Issue 6 (8th April 2015) Authors: Henry, R. R.; Buse, J. B.; Wu, H.; Durrwell, L.; Mingrino, R.; Jaekel, K.; El Azzouzi, B.; Andjelkovic, M.; Herz, M. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P22-18 The linkage between cadmium and insulin resistance – integrating bioinformatics approach with Benchmark modeling of human data. (1st September 2022) Authors: Ðukić-Ćosić, D.; Baralic, K.; Javorac, D.; Maric, D.; Andjelkovic, M.; Curcic, M.; Repic, A.; Antonijevic, B.; Bulat, Z.; Djordjevic, A. Buha Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P37 Trial design of the GRADUATE studies: Phase III, randomized, placebo-controlled studies evaluating gantenerumab in patients with early Alzheimer's disease. Issue 8 (August 2019) Authors: Boada, M.; Ristic, S.; Pross, N.; Abi-Saab, D.; Bullain, S.; Andjelkovic, M.; Peters, O.; Delmar, P.; Hofmann, C.; Searle, A.; Baudler, M.; Fontoura, P.; Doody, R. Journal: Clinical neurophysiology Issue: Volume 130:Issue 8(2019:Aug.) Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pleckstrin homology domains. (August 1995) Authors: Frech, M.; Ingley, E.; Andjelkovic, M.; Hemmings, B. A. Journal: Biochemical Society transactions Issue: Volume 23:Number 3(1995) Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prediction of solar particle events with SRAM-based soft error rate monitor and supervised machine learning. (November 2020) Authors: Chen, J.; Lange, T.; Andjelkovic, M.; Simevski, A.; Krstic, M. Journal: Microelectronics and reliability Issue: Volume 114(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Taspoglutide, a once‐weekly glucagon‐like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open‐label randomized trial. Issue 1 (13th December 2012) Authors: Nauck, M.; Horton, E.; Andjelkovic, M.; Ampudia‐Blasco, F. J.; Parusel, C. T.; Boldrin, M.; Balena, R. Journal: Diabetic medicine Issue: Volume 30:Issue 1(2013:Jan.) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Thermal drift reduction in photodiode dosimeters with switching bias. (August 2022) Authors: Ruiz-García, I.; Román-Raya, J.; Escobedo, P.; Andjelkovic, M.; Guirado, D.; Palma, A.J.; Carvajal, M.A. Journal: Measurement Issue: Volume 199(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗